Found: 14
Select item for more details and to access through your institution.
Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4421, doi. 10.1093/cid/ciaa648
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 3, p. 1, doi. 10.1093/ofid/ofad069
- By:
- Publication type:
- Article
Clinical outcomes and immune responses to SARS‐CoV‐2 vaccination in severe aplastic anaemia.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 5, p. 679, doi. 10.1111/bjh.18456
- By:
- Publication type:
- Article
Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26579-z
- By:
- Publication type:
- Article
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48514-8
- By:
- Publication type:
- Article
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42098-5
- By:
- Publication type:
- Article
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 728, p. 1, doi. 10.1126/scitranslmed.add5960
- By:
- Publication type:
- Article
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 692, p. 1, doi. 10.1126/scitranslmed.ade9078
- By:
- Publication type:
- Article
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 676, p. 1, doi. 10.1126/scitranslmed.ade0424
- By:
- Publication type:
- Article
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 184, doi. 10.1002/cpt.2026
- By:
- Publication type:
- Article
Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12423-x
- By:
- Publication type:
- Article
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1.
- Published in:
- Advanced Science, 2024, v. 11, n. 26, p. 1, doi. 10.1002/advs.202309268
- By:
- Publication type:
- Article
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 10, p. 2029, doi. 10.3390/v15102029
- By:
- Publication type:
- Article